Secondary Amenorrhea After Hodgkin’s Lymphoma Is Influenced by Age at Treatment, Stage of Disease, Chemotherapy Regimen, and the Use of Oral Contraceptives During Therapy: A Report From the German Hodgkin’s Lymphoma Study Group - Behringer, Karolin; Breuer, Kai; Reineke, Thorsten; May, Michael; Nogova, Lucia; Klimm, Beate; Schmitz, Tatiana; Wildt, Ludwig; Diehl, Volker; Engert, Andreas (Journal of clinical oncology, 2005)
Keywords: Adolescent; Adult; Age Factors; Aged; Amenorrhea - etiology; Antineoplastic Combined Chemotherapy Protocols - therapeutic use; Biological and medical sciences; Bleomycin - therapeutic use; Combined Modality Therapy; Contraceptives, Oral; Cyclophosphamide - therapeutic use; Dacarbazine - therapeutic use; Disease-Free Survival; Doxorubicin - therapeutic use; Etoposide - therapeutic use; Female; Female genital diseases; Gynecology. Andrology. Obstetrics; Hodgkin Disease - drug therapy; Hodgkin Disease - radiotherapy; Humans; Male; Medical sciences; Menstrual Cycle; Middle Aged; Neoplasm Staging; Non tumoral diseases; Prednisone - therapeutic use; Procarbazine - therapeutic use; Risk Factors; Treatment Outcome; Tumors; Vinblastine - therapeutic use; Vincristine - therapeutic use; Europe; Germany; Menstruation disorders; Secondary; Oral administration; Hodgkin disease; Malignant hemopathy; Lymphoma; Female genital diseases; Chemotherapy; Clinical stage; Cancerology; Treatment; Lymphoproliferative syndrome; Amenorrhea; Contraceptive; Age